GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Eyebright Medical Technology (Beijing) Co 688050.SS · CNY

Health Care · Shanghai · 🇨🇳 China

Compare

42.53

-2.70%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Eyebright Medical Technology (Beijing) Co

Its shares trade on Shanghai under the ticker 688050.SS. It has been listed since 29 July 2020. In the fiscal year to 31 December 2025, it reported revenue of CN¥1.48bn and net income of CN¥265.4m. At that date it held total assets of CN¥3.89bn and shareholders' equity of CN¥2.79bn.

Eyebright Medical Technology (Beijing) Co., Ltd. engages in the research and development, production, sales and related services of ophthalmic medical equipment and devices. The company is headquartered in Beijing, Beijing. The company went IPO on 2020-07-29. Its main products include ophthalmic surgery and optometry. Surgical products mainly include intraocular lens, capsular tension ring, intraocular lens implantation system, ophthalmic viscoelastic agent, various types of ophthalmic microsurgical instruments and ophthalmic scalpels, and optometry products include corneal orthopaedics (night-wear type), hard contact lens (daily-wear type) and tear test paper, among others. The firm conducts its businesses in domestic and overseas markets.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
29 Jul 2020
Employees
871

Leadership

Pay as last reported

  • Mr. Jiangbing XieChairman of the Board, Chief Scientific Officer, General Manager, since 2019CN¥1.3m
  • Mr. Yanchang GuoChief Financial Officer, Deputy General ManagerCN¥750,700
  • Ms. Shaohua WangChief Operating Officer,Senior Deputy General Manager, Director, since 2019CN¥758,300
  • Ms. Zhao WangDeputy General Manager, Director, Director of Research & Development, since 2020CN¥894,600
  • Mr. Baoshan JiaDeputy General Manager, Director of National Marketing and SalesCN¥1.6m
  • Ms. Jie YuHead of R&D ProjectCN¥349,500
  • Ms. Yuqian ZhouSecretary of the BoardCN¥567,300
  • Mr. Yong ChenDirector
  • Ms. Yu FangDirector
  • Mr. Yongji WeiStaff Elected DirectorCN¥517,000
  • Mr. Feng JiangIndependent DirectorCN¥160,000
  • Mr. Xinyu LengIndependent DirectorCN¥160,000

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
64
Environment
71
Social
73
Governance
48
Women in the workforce
58%
Carbon reduction policy
Yes
Human rights policy
Yes

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Company is headquartered in Beijing with 871 employees.
  • Offers a range of ophthalmic medical equipment and devices.
  • Conducts business in both domestic and overseas markets.

Weaknesses

  • No specific weaknesses mentioned in the provided information.
  • No details on financial performance or market share provided.
  • No information on competitive advantages or unique technologies.

Opportunities

  • Expansion into ophthalmic surgery and optometry markets.
  • Growth potential in domestic and overseas markets.
  • Potential for increased sales of ophthalmic medical equipment.

Threats

  • No specific threats mentioned in the provided information.
  • No details on market competition or regulatory challenges.
  • No information on economic or industry risks.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.